REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioinfra Co.,Ltd. (South Korea)

Main Activities: Scientific Research and Development Services
Full name: Bioinfra Co.,Ltd. Profile Updated: July 04, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Bioinfra Co.,Ltd. is engaged in the research and development of pharmaceuticals. The company also offers products such as research and development of drugs, non-clinical and clinical trials, health functional foods and others. Bioinfra Co.,Ltd. was incorporated in 2007 and is based in Yongin, South Korea.

Headquarters
120, Heungdeokjungang-ro Giheung-gu Yongin-si Gyeonggi
Yongin; Gyeonggi;

Contact Details: Purchase the Bioinfra Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Bioinfra Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Bioinfra Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Bioinfra Co.,Ltd. report to view the information.
Incorporation Date:
May 23, 2007
Key Executives
Purchase this report to view the information.
CEO
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Non-Executive Independent Director
Purchase this report to view the information.
Auditor
Purchase this report to view the information.
Vice President
Company Performance
Financial values in the chart are available after Bioinfra Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
15.94%
Total operating revenue
15.94%
Operating profit (EBIT)
-14.77%
EBITDA
-3.5%
Net Profit (Loss) for the Period
0.05%
Total assets
-3.41%
Total equity
64.88%
Operating Profit Margin (ROS)
-6.47%
Net Profit Margin
-2.79%
Return on Equity (ROE)
-22.56%
Debt to Equity Ratio
-87.37%
Quick Ratio
-0.04%
Cash Ratio
0.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?